SCHEMBL5636210

SCHEMBL5636210

[CH2]C(CCC(C)C)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17506485 0.83 LMNA (0.43)
SCHEMBL17502740 0.81 LMNA (0.42)
SCHEMBL17502732 0.81 LMNA (0.42)
SCHEMBL17502728 0.81 LMNA (0.42)
SCHEMBL17502609 0.81 LMNA (0.42)
SCHEMBL17502706 0.81 LMNA (0.42)
SCHEMBL17502719 0.81 LMNA (0.42)
SCHEMBL17509528 0.79 ALDH1A1 (0.30)
SCHEMBL17509532 0.79
SCHEMBL11201987 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39679-E1 Substituted heterocycle fused gamma-carbolines BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-06-05 US claimed
WO-2016025194-A1 COMBINED INTERNAL DONOR SYSTEM FOR ZIEGLER-NATTA POLYOLEFIN CATALYSTS AND METHODS OF MAKING AND USING SAME BASF CORPORATION (US) 2016-02-18 WO disclosed